In the following, we will summarize studies that have analyzed PCSK9 levels and lipoproteins in patients and experimental models suffering from metabolic disorders, including diabetes, obesity as well as inflammation and chronic liver injury. The gene discussed is PCSK9; the disease is Obesity.